Home Cart 0 Sign in  

[ CAS No. 10102-94-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 10102-94-0
Chemical Structure| 10102-94-0
Structure of 10102-94-0 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 10102-94-0 ]

Related Doc. of [ 10102-94-0 ]

Alternatived Products of [ 10102-94-0 ]
Product Citations

Product Details of [ 10102-94-0 ]

CAS No. :10102-94-0 MDL No. :MFCD03906373
Formula : C10H8BrNO Boiling Point : -
Linear Structure Formula :- InChI Key :NZJJLQUTQOICBN-UHFFFAOYSA-N
M.W : 238.08 Pubchem ID :778451
Synonyms :

Calculated chemistry of [ 10102-94-0 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.1
Num. rotatable bonds : 1
Num. H-bond acceptors : 1.0
Num. H-bond donors : 0.0
Molar Refractivity : 56.29
TPSA : 22.0 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.23 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.12
Log Po/w (XLOGP3) : 2.15
Log Po/w (WLOGP) : 2.75
Log Po/w (MLOGP) : 1.88
Log Po/w (SILICOS-IT) : 2.74
Consensus Log Po/w : 2.33

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.12
Solubility : 0.182 mg/ml ; 0.000764 mol/l
Class : Soluble
Log S (Ali) : -2.24
Solubility : 1.36 mg/ml ; 0.0057 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.65
Solubility : 0.0529 mg/ml ; 0.000222 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.34

Safety of [ 10102-94-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 10102-94-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 10102-94-0 ]

[ 10102-94-0 ] Synthesis Path-Downstream   1~18

  • 1
  • [ 10102-94-0 ]
  • [ 41003-94-5 ]
  • [ 90289-62-6 ]
  • [ 90289-63-7 ]
YieldReaction ConditionsOperation in experiment
90.1% General procedure: 5-Fluoroindole-3-carbaldehyde (0.5 g, 3.07 mmol) and tetrahydrofuran (10 mL) were sequentially added to a 100 mL one-neck round bottom flask, cooled to 0 C, and slowly added NaH (60%, 196 mg, 4.91 mmol) After reacting for 10 minutes,Transfer to room temperature for 1 h, add MeI (0.38 mL, 6.14 mmol),The reaction was carried out at room temperature for 15.5 h, quenched with water (5 mL), and then evaporated to ethyl ether (ethyl acetate) (ethyl acetate (40mL×1)), washed with water (20mL×3), and then ethyl acetate was collected and then purified by column chromatography ( petroleum ether) /ethyl acetate (v/v) = 5/1) to give the title compound as a white solid(0.50 g, 92%).
  • 4
  • [ 19012-03-4 ]
  • [ 10102-94-0 ]
  • [ 25055-65-6 ]
  • [ 25055-66-7 ]
  • N-methyl-2,6-dibromoindole-3-carbaldehyde [ No CAS ]
  • 5
  • [ 877-03-2 ]
  • [ 74-88-4 ]
  • [ 10102-94-0 ]
YieldReaction ConditionsOperation in experiment
96% 5-bromoindole-3-carbaldehyde 2 (10 mmol) was dissolved in acetonitrile and to this powdered NaOH (5 mmol) was added and stirred for 10 min. Methyl iodide (10 mmol) was added dropwise to the reaction mixture. After 3h of stirring at room temperature, the solvent was completely evaporated. It was extracted with ethyl acetate (3x20 ml) and dried over Na2SO4. The combined organic layer was concentrated in vacuo to give a light yellow color solid purified by recrystallization with diethyl ether. Pale yellow solid; Yield: 96%; mp 122-124 C; IR (KBr) numax 3103, 2923, 2813, 1700, 1654. 1533, 1467, 1369, 1083, 799, 726; 1H NMR (DMSO-d6, 300 MHz) delta 9.88 (s, 1H), 8.33 (s, 1H), 8.23 (d, J = 1.70 Hz, 1H), 7.60 (d, J = 8.68 Hz, 1H), 7.48 (dd, J = 2.08, 8.87 Hz, 1H), 3.89 (s, 3H); TOF-HRMS (m/z) for C10H8BrNO, calculated 237.9862, observed 237.9855 [M+1] +
91% With sodium hydride; In tetrahydrofuran; at 0℃; for 1.83333h; 5-Bromo-1-methyl-lH-indole-3-carbaldehyde; 5-Bromo-1H-indole-3-carbaldehyde (4.8 mmol, 1076 mg) was dissolved in 15 mL of THF and the solution was cooled to 0 C under N2-athmosphere. Sodium hydride (11.7 mmol, 280 mg) was added carefully in portions and iodomethane (8.1 mmol, 1150 mg) was added. The mixture was stirred at 0 C for 1 h. More iodomethane (8.1 mmol, 1150 mg) was added and the stirring continued for 50 min. The mixture was poured over ice and the resulting slurry was extracted with EtOAc. The organic layer was dried over Na2SO4, filtered and evaporated. This gave 1037 mg (91 %) of the title product. 'H NMR (400 MHz, MeOH-d4) 8 9.82 (s, 1H), 8,29 (m, 1H), 8.06 (s, 1H), 7.43 (m, 2H), 3.89 (s, 3H)
81% General procedure: To a suspension of NaH 60% in oil (2.25 equiv.) in dry DMF(0.8 mL/mmol) was added, at 0 C and under nitrogen atmosphere, a solution of indolecarboxaldehyde (1 equiv.) in dry DMF (2.5 mL/mmol). After stirring for 30 min at rt, alkyl halide (1.0e3.0 equiv.)was slowly added. After stirring overnight, the reaction wasquenched by addition of water and the product was extracted withdiethyl ether. The organic layer was dried over MgSO4, filtered offand concentrated under vacuum. The crude product was purifiedby column chromatography on silica gel.
General procedure: Compounds 7-9 were synthesized from the corresponding compounds 4-6. A solution of compounds 4-6 (60 mmol) in THF (30 mL) were added dropwise to a suspension of NaH (3.60 g, 60% dispersion in mineral oil, 150 mmol) in THF (30 mL) at 0 C. After stirring for 15 min, the heterogeneous mixture was treated with iodomethane (5.04 mL, 79.2 mmol) at room temperature for 1 h. Then the reaction mixture was cooled to 0 C, quenched with saturated NH4Cl (60 mL), and extracted with ether (3 * 50 mL). The organic layers were combined, washed with brine, dried over anhydrous Na2SO4 and concentrated in vacuo to give 1-Methyl-1H-indole-3-carboxaldehyde (7-9), a light brown solid. The crude 7-9 were used in the next step without any further purification.
With sodium hydride; In tetrahydrofuran; at 0 - 20℃; for 24h; General procedure: The relevant indole-3-carboxaldehyde (2a-c, 10 mmol) in THF(25 mL) was added dropwise to a stirred solution of NaH (25 mmol)in THF (25 mL) at 0 C and CH3I (13.2 mmol) was added after 15 minstirring. The reaction mixturewas moved to room temperature andstirred for further 24 h. Then the solvent was removed in vacuumand the residue was extracted by ethyl acetate. The organic layerwas washed with brine, dried over anhydrous sodium sulfate,filtered and concentrated in vacuum. Recrystallization affordedcompound 3a-c with yields of 93.4-97.5%.

  • 7
  • [ 10102-94-0 ]
  • [ 38622-91-2 ]
  • 5-(5'-bromo-1'-methyl-3'-indolyl)oxazole [ No CAS ]
  • 8
  • [ 10102-94-0 ]
  • [ 31499-72-6 ]
  • 1-(5-bromo-1-methyl-1H-indol-3-yl)-5-(2,6,6-trimethylcyclohex-2-enyl)-pent-1-en-3-one [ No CAS ]
  • 9
  • [ 10102-94-0 ]
  • [ 7333-52-0 ]
  • 5-bromo-3-cyclopentylidenemethyl-1-methyl-1<i>H</i>-indole [ No CAS ]
  • 10
  • [ 931127-52-5 ]
  • [ 10102-94-0 ]
  • 4-(5-bromo-1-methyl-1<i>H</i>-indol-3-ylmethylene)-5-[1,2,3]thiadiazol-5-yl-2,4-dihydro-pyrazol-3-one [ No CAS ]
  • 12
  • [ 10102-94-0 ]
  • C30H32Br2N2 [ No CAS ]
  • 13
  • [ 10102-94-0 ]
  • 5-bromo-1-methyl-1<i>H</i>-indole-3-carboxylic acid pyridin-4-ylamide [ No CAS ]
  • 14
  • [ 10102-94-0 ]
  • 5-bromo-1-methyl-1<i>H</i>-indole-3-carboxylic acid (4,6-dimethyl-pyridin-2-yl)-amide [ No CAS ]
  • 15
  • [ 860297-17-2 ]
  • [ 10102-94-0 ]
  • C27H31BrN4O [ No CAS ]
  • 17
  • [ 10102-94-0 ]
  • [ 3481-02-5 ]
  • C20H18BrNO2 [ No CAS ]
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 10102-94-0 ]

Bromides

Chemical Structure| 17826-04-9

[ 17826-04-9 ]

6-Bromo-1H-indole-3-carbaldehyde

Similarity: 0.93

Chemical Structure| 400071-95-6

[ 400071-95-6 ]

5-Bromo-1-methyl-1H-indole-3-carboxylic acid

Similarity: 0.86

Chemical Structure| 10075-49-7

[ 10075-49-7 ]

5-Bromo-1,3-dimethyl-1H-indole

Similarity: 0.85

Chemical Structure| 332366-57-1

[ 332366-57-1 ]

6-Bromoquinolin-4(1H)-one

Similarity: 0.84

Chemical Structure| 944086-09-3

[ 944086-09-3 ]

1-(7-Bromo-1H-indol-3-yl)ethanone

Similarity: 0.83

Aldehydes

Chemical Structure| 17826-04-9

[ 17826-04-9 ]

6-Bromo-1H-indole-3-carbaldehyde

Similarity: 0.93

Chemical Structure| 98600-34-1

[ 98600-34-1 ]

4-Bromoindole-3-carboxyaldehyde

Similarity: 0.82

Chemical Structure| 877-03-2

[ 877-03-2 ]

5-Bromo-1H-indole-3-carbaldehyde

Similarity: 0.82

Chemical Structure| 19012-03-4

[ 19012-03-4 ]

1-Methyl-1H-indole-3-carbaldehyde

Similarity: 0.80

Chemical Structure| 133994-99-7

[ 133994-99-7 ]

1-Methyl-1H-indole-4-carbaldehyde

Similarity: 0.77

Related Parent Nucleus of
[ 10102-94-0 ]

Indoles

Chemical Structure| 17826-04-9

[ 17826-04-9 ]

6-Bromo-1H-indole-3-carbaldehyde

Similarity: 0.93

Chemical Structure| 400071-95-6

[ 400071-95-6 ]

5-Bromo-1-methyl-1H-indole-3-carboxylic acid

Similarity: 0.86

Chemical Structure| 10075-49-7

[ 10075-49-7 ]

5-Bromo-1,3-dimethyl-1H-indole

Similarity: 0.85

Chemical Structure| 944086-09-3

[ 944086-09-3 ]

1-(7-Bromo-1H-indol-3-yl)ethanone

Similarity: 0.83

Chemical Structure| 98600-34-1

[ 98600-34-1 ]

4-Bromoindole-3-carboxyaldehyde

Similarity: 0.82

; ;